BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18221041)

  • 1. Recent patents therapeutic agents for cancer.
    Li X; Xu W
    Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):255-84. PubMed ID: 18221041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview on the development of new potentially active camptothecin analogs against cancer.
    Chazin Ede L; Reis Rda R; Junior WT; Moor LF; Vasconcelos TR
    Mini Rev Med Chem; 2014; 14(12):953-62. PubMed ID: 25355593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The multidrug tumor cell resistance phenotype caused by the impaired cell death program].
    Blokhin DIu
    Vestn Ross Akad Med Nauk; 2004; (12):16-20. PubMed ID: 15678683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug therapy for inoperable gastric cancer: current possibilities and perspectives of development].
    Volkov NM; Moiseenko VM
    Vopr Onkol; 2007; 53(4):383-92. PubMed ID: 17969398
    [No Abstract]   [Full Text] [Related]  

  • 5. Platinum complexes as anticancer agents.
    Kostova I
    Recent Pat Anticancer Drug Discov; 2006 Jan; 1(1):1-22. PubMed ID: 18221023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer.
    Grivicich I; Mans DR; Peters GJ; Schwartsmann G
    Braz J Med Biol Res; 2001 Sep; 34(9):1087-103. PubMed ID: 11514832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of advanced disease and new drugs.
    Frustaci S; Buonadonna A; La Mura N; Berretta M; De Paoli A
    Suppl Tumori; 2003; 2(5):S48-50. PubMed ID: 12914391
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent Developments in the Field of Anticancer Platinum Complexes.
    Galanski MS
    Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):285-95. PubMed ID: 18221042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel camptothecin derivatives.
    Legarza K; Yang LX
    In Vivo; 2005; 19(1):283-92. PubMed ID: 15796188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topoisomerase I inhibitors: topotecan and irenotecan.
    Creemers GJ; Lund B; Verweij J
    Cancer Treat Rev; 1994 Jan; 20(1):73-96. PubMed ID: 8293429
    [No Abstract]   [Full Text] [Related]  

  • 11. Topoisomerase inhibitors. A review of their therapeutic potential in cancer.
    Sinha BK
    Drugs; 1995 Jan; 49(1):11-9. PubMed ID: 7705211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel anticancer drugs in Japan.
    Ogawa M
    J Cancer Res Clin Oncol; 1999; 125(3-4):134-40. PubMed ID: 10235466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reflections on the development of resistance during therapy for advanced breast cancer. Implications of high levels of activity of docetaxel in anthracycline-resistant breast cancer patients.
    Ravdin PM
    Eur J Cancer; 1997 Aug; 33 Suppl 7():S7-10. PubMed ID: 9486096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiles as biomarkers for the prediction of chemotherapy drug response in human tumour cells.
    Parissenti AM; Hembruff SL; Villeneuve DJ; Veitch Z; Guo B; Eng J
    Anticancer Drugs; 2007 Jun; 18(5):499-523. PubMed ID: 17414620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podophyllotoxin: History, Recent Advances and Future Prospects.
    Shah Z; Gohar UF; Jamshed I; Mushtaq A; Mukhtar H; Zia-Ui-Haq M; Toma SI; Manea R; Moga M; Popovici B
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33921719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topoisomerase I inhibitors: topotecan and irinotecan.
    Jones SF; Burris HA
    Cancer Pract; 1996; 4(1):51-3. PubMed ID: 8788772
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthetic and application perspectives of azapodophyllotoxins: alternative scaffolds of podophyllotoxin.
    Kumar A; Kumar V; Alegria AE; Malhotra SV
    Curr Med Chem; 2011; 18(25):3853-70. PubMed ID: 21824101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Five cytostatic substances in animal studies for prevention and treatment of experimentally induced peritoneal carcinomatosis].
    Hribaschek A; Pross M; Ridwelski K; Meyer F; Fenske A; Krüger S; Lippert H
    Zentralbl Chir; 2004 Aug; 129(4):328-34. PubMed ID: 15354258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review on Camptothecin Analogs with Promising Cytotoxic Profile.
    Amin SA; Adhikari N; Jha T; Gayen S
    Anticancer Agents Med Chem; 2018; 18(13):1796-1814. PubMed ID: 29589546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy in gastric cancer: a brief chronicle with emphasis on recent developments.
    Sulkes A
    Isr Med Assoc J; 2004 Jul; 6(7):415-9. PubMed ID: 15274533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.